|
|
侺ÙÅÂì ÍÁµÁËÑ·¸¹Ð | 3 | ![](/images/barhorange.gif) | 1.41 |
ÊØ¢ÀÒ¾¼ÙéºÃÔâÀ¤ | 3 | ![](/images/barhorange.gif) | 1.41 |
§Ò¹ºÃÔ¡ÒâéÍÁÙżÅÔµÀѳ±ìÊØ¢ÀÒ¾¼èÒ¹ÍÔ¹àµÍÃìà¹çµ | 3 | ![](/images/barhorange.gif) | 1.41 |
ÂÒ¹éÓÊÁعä¾ÃâËÂè§àËÔ§ | 3 | ![](/images/barhorange.gif) | 1.41 |
ºÃóҹءÃÁ pharmacopeia usp 2008 | 2 | ![](/images/barhorange.gif) | 0.94 |
¤¹à»ç¹ÊÔÇàÅ×Í¡¤ÃÕÁ¡Ñ¹á´´áººä˹´Õ | 2 | ![](/images/barhorange.gif) | 0.94 |
¹éÓà¡Å×Í ¢Ò´µÅÒ´ | 2 | ![](/images/barhorange.gif) | 0.94 |
¢éÍÁÙÅ¡¯ËÁÒ ÍÂ. | 2 | ![](/images/barhorange.gif) | 0.94 |
â¤Ã§ §Ò¹àÃ×èͧ áÍÅ¡ÍÎÍÅìáç§ | 2 | ![](/images/barhorange.gif) | 0.94 |
ÂÒʵÃÕ¹ÔÊÔ§àË | 2 | ![](/images/barhorange.gif) | 0.94 |
ÂÒ ÊµÃÕ à¾ç ÀÒ¤ ÊÃþ¤Ø³ | 2 | ![](/images/barhorange.gif) | 0.94 |
â¤Ã§¡ÒÃà¹×éÍÊѵÇì͹ÒÁÑ | 2 | ![](/images/barhorange.gif) | 0.94 |
ÍÂ | 2 | ![](/images/barhorange.gif) | 0.94 |
ÍÒËÒÃà¾×èÍÊØ¢ÀÒ¾ Í. | 2 | ![](/images/barhorange.gif) | 0.94 |
ÃÒª×èÍ˹ѧÊ×Í ¡ÒüÅÔµÍÒËÒáÃлëͧ | 2 | ![](/images/barhorange.gif) | 0.94 |
¡ÒúÃÔâÀ¤¼ÅÔµÀѳ±ìÊØ¢ÀÒ¾ | 2 | ![](/images/barhorange.gif) | 0.94 |
powerpoint àÃ×èͧÊÒÃà¤ÁÕ¡èÍÁÐàÃç§ã¹ÍÒËÒà | 2 | ![](/images/barhorange.gif) | 0.94 |
¼ÅàÊÕ¢ͧ¡ÅÙµéÒä¸â͹ | 2 | ![](/images/barhorange.gif) | 0.94 |
ÂÒठ¤×Í | 2 | ![](/images/barhorange.gif) | 0.94 |
aromatology ËÁÒ¶֧ | 2 | ![](/images/barhorange.gif) | 0.94 |
ÇÔ¨ÑÂà¡ÕèÂǡѺÂҪش | 2 | ![](/images/barhorange.gif) | 0.94 |
§Ò¹ÇÔ¨ÑÂà¡ÕèÂǡѺÂҪش | 2 | ![](/images/barhorange.gif) | 0.94 |
ÊÕ¼ÊÁÍÒËÒà ÂéÍÁ¼éÒä´éÁÑé | 1 | ![](/images/barhorange.gif) | 0.47 |
ÍÒËÒÃÅÐÅÒÂÅÔèÁàÅ×Í´äÁèãËéá¢ç§µÑÇ | 1 | ![](/images/barhorange.gif) | 0.47 |
ËéͧÊÁØ´ Í | 1 | ![](/images/barhorange.gif) | 0.47 |
Áҵðҹ¢¹ÁàÇà¿ÍÃì Í | 1 | ![](/images/barhorange.gif) | 0.47 |
ʸ ¼ÅÔµäÇÍÒ¡ÃéÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
chronic venous insufficiency ¤×Í | 1 | ![](/images/barhorange.gif) | 0.47 |
tobramycin ÊÃþ¤Ø³ | 1 | ![](/images/barhorange.gif) | 0.47 |
àÍ¡ÊÒ÷ӺѵÃ30ºÒ· | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒ ÊµÃÕ ¹Ô ÊÔ§ àË ËÁÍ ÁÕ | 1 | ![](/images/barhorange.gif) | 0.47 |
¢éÍ´Õ ¢éÍàÊÕ¢ͧ ¡ÅÙµéÒä¸â͹ | 1 | ![](/images/barhorange.gif) | 0.47 |
¼Å¢éÒ§à¤Õ§¢Í§¡ÅÙµéÒä¸â͹µèÍÃèÒ§¡Ò | 1 | ![](/images/barhorange.gif) | 0.47 |
doxil chemotherapy drugs for sarcoma cancer ÂÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
¹éÓµÒÅÁÍŵԷÍÅä«ÃÑ» µÃÒÃÕÅ | 1 | ![](/images/barhorange.gif) | 0.47 |
powerpoint àÃ×èͧ ÊÒÃàÃè§à¹×éÍá´§ | 1 | ![](/images/barhorange.gif) | 0.47 |
º·¤Ñ´ÂèÍ¡Ò÷ÓáÍÅ¡ÍÎÍÅìá¢ç | 1 | ![](/images/barhorange.gif) | 0.47 |
ÃÒ§ҹ¼ÅÔµÀѳ±ìà¾×èÍÊØ¢ÀÒ¾ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÁÔ´Òâ«áÅÁ | 1 | ![](/images/barhorange.gif) | 0.47 |
·íÒ¤ÍÁãËéàËÁ×͹ãËÁè | 1 | ![](/images/barhorange.gif) | 0.47 |
à¹×éÍËÒàÃ×èͧ¡ÒÃâ¦É³Ò | 1 | ![](/images/barhorange.gif) | 0.47 |
¢éÍ´Õ ¢éÍàÊÕ ÍâǤÒâ´é | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒ floctafenine | 1 | ![](/images/barhorange.gif) | 0.47 |
¼èҵѴà¹×éͧ͡ ·Õè þ ÃÒªÇÔ¶Õ | 1 | ![](/images/barhorange.gif) | 0.47 |
¢Ò «ÔÅàÇÍÃìä¹àµÃ´ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÃÑ¡ÉÒ·Ò§ÇÔ·ÂØ »ÃÐà·È | 1 | ![](/images/barhorange.gif) | 0.47 |
»ÃÐ⪹ì¢Í§ÊÒáÅÙµéÒä¸â͹ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÍѹµÃÒ¨ҡ¡ÒÃãªéÂÒ»¯ÔªÕǹР| 1 | ![](/images/barhorange.gif) | 0.47 |
ÍЫԫÑÅà¿Á-ठ| 1 | ![](/images/barhorange.gif) | 0.47 |
¾ÄµÔ¡ÃÃÁ¡ÒÃãªèÂҪش | 1 | ![](/images/barhorange.gif) | 0.47 |
¢éÍÁÙÅ ¾Ãº. Çѵ¶ØÍѹµÃÒ ¾.È 2535 ppt | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂҪش | 1 | ![](/images/barhorange.gif) | 0.47 |
§Ò¹ÇÔ¨ÑÂÊÒþÔÉã¹à¤Ã×èͧÊÓÍÒ§ | 1 | ![](/images/barhorange.gif) | 0.47 |
¤é¹ËÒª×èÍâä crohn's áÅÐÈѾ·ì·Ò§¡ÒÃá¾·Âì | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒá¡éä¢é | 1 | ![](/images/barhorange.gif) | 0.47 |
§Ò¹ÇԨѡÅÙµéÒä¸â͹ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÈعÂìÇԨѡÊÔ¡Ãä·Â + à¤Ã×èͧ»ÃاÃÊ | 1 | ![](/images/barhorange.gif) | 0.47 |
paracetamol ÊÃþ¤Ø³ | 1 | ![](/images/barhorange.gif) | 0.47 |
áÁ§ÁØÁÁÕ¾ÔÉ ã¹àÁ×ͧä·Â | 1 | ![](/images/barhorange.gif) | 0.47 |
statistical techniques for signal generation: the australian experience. | 1 | ![](/images/barhorange.gif) | 0.47 |
ÍѹµÃÒ àÁç´á»Ð¡êÇ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒÇÒ¿ÒÃÔ¹ | 1 | ![](/images/barhorange.gif) | 0.47 |
µÒÃÒ§¡ÒùÓà¢éÒÂÒ㹻Ѩ¨ØºÑ¹ | 1 | ![](/images/barhorange.gif) | 0.47 |
¼ÅàÊÕ¡ÅÙµéÒä¸â͹ẺàÁç´ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÃÇÁà¨éҢͧÂÒʵÃÕ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÇèÒ¹ªÑ¡Á´ÅÙ¡ µÃÒÃÒªÊÕËì | 1 | ![](/images/barhorange.gif) | 0.47 |
¡Ã´«ÒÅÔä«ÅÔ¡ ã¹ÍصÊÒË¡ÃÃÁ¼ÅÔµáÍÊä¾ÅÔ¹ | 1 | ![](/images/barhorange.gif) | 0.47 |
Áҵðҹ¡ÅéÇÂä¢èÊè§ÍÍ¡ | 1 | ![](/images/barhorange.gif) | 0.47 |
¡Í§¤Çº¤ØÁÍÒËÒà ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ÍпÅÒ·Íê¡«Ô¹ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÍÒ¡Òâͧ¤¹·Õèèä´éÃѺ¾Ôɨҡ¹éÓÂÒÅéÒ§Ëéͧ¹éÓ | 1 | ![](/images/barhorange.gif) | 0.47 |
Áҵðҹ¹éÓºÃÔâÀ¤¢Í§Í§¤ì¡ÒÃÍÒËÒÃáÅÐÂÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
¼Å¢Í§ÂÒÍÍÃì¿ÒÃÔ¹µèÍ·Òá㹤ÃÃÀì | 1 | ![](/images/barhorange.gif) | 0.47 |
ÇÔ¸Õ·ÓáÍÅ¡ÍÎÍáËé§ | 1 | ![](/images/barhorange.gif) | 0.47 |
»ÃÐàÀ·¢Í§ÂÒ´ÁÊź anesthesia | 1 | ![](/images/barhorange.gif) | 0.47 |
º·¤Ñ´ÂèÍ¡ÒÃÊ¡Ñ´ÊÕ¨Ò¡¸ÃÃÁªÒµÔ | 1 | ![](/images/barhorange.gif) | 0.47 |
¡ÒèѴ¨éÒ§¨Ò¡ÀÒ¹͡ | 1 | ![](/images/barhorange.gif) | 0.47 |
¡ÒÃÊ¡Ñ´ÊÒà «ÒÅÔ«Ôàŵ ¨Ò¡¼ÅäÁé | 1 | ![](/images/barhorange.gif) | 0.47 |
¡Ò÷´Êͺ¡Òªã¹ÍÒËÒáÃлëͧ | 1 | ![](/images/barhorange.gif) | 0.47 |
§Ò¹ÇÔ¨ÑÂà¡ÕèÂǡѺ ÍÒËÒÃáÅÐÂÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
¡ÙŵéÒä¸âÎÏ ÁÕ»ÃÐ⪹ì | 1 | ![](/images/barhorange.gif) | 0.47 |
·ÒÁÔ¿ÅÙ¡ÒáԹ | 1 | ![](/images/barhorange.gif) | 0.47 |
â·¹àÍàÍçÁ | 1 | ![](/images/barhorange.gif) | 0.47 |
ª¹Ô´¢Í§¡ÅÙµéÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒʵÃÕà¾çÀÒ¤ ÊÔÇ | 1 | ![](/images/barhorange.gif) | 0.47 |
¢èÒÇÍѹµÃÒ¨ҡ¡ÅÙµéÒä¸â͹ Í. ¹éÍ | 1 | ![](/images/barhorange.gif) | 0.47 |
Áҵðҹ¢Í§ ÊÕ¼ÊÁÍÒËÒà | 1 | ![](/images/barhorange.gif) | 0.47 |
¹éÓ¾ÃÔ¡¡Øé§àÊÕº ¨Ñ§ËÇÑ´¡ÃкÕè | 1 | ![](/images/barhorange.gif) | 0.47 |
Ẻ¿ÍÃìÁ¤Ñ´¡Ãͧ¹Ñ¡àÃÕ¹·ÕèÁÕÀÒзҧÊÁÒ¸ÔÊÑé¹ º¡¾Ãèͧ·Ò§¡ÒÃàÃÕ¹ÃÙé ÍÍ·Ô«ÖÁ | 1 | ![](/images/barhorange.gif) | 0.47 |
hot issue äŻԴ | 1 | ![](/images/barhorange.gif) | 0.47 |
¡ÒÃÇÔà¤ÃÒÐËì swot ¢Í§ºÃÔÉÑ· ¡ÒúԹä·Â | 1 | ![](/images/barhorange.gif) | 0.47 |
¼Å¢éÒ§à¤Õ§ÂÒasa | 1 | ![](/images/barhorange.gif) | 0.47 |
30ºÒ·ÃÑ¡ÉÒ·Ø¡âä ÃÐàºÕº | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒ·ÕèÃéÒ¹¤éÒÊÒÁÒö¹ÓÁÒ¢ÒÂä´é | 1 | ![](/images/barhorange.gif) | 0.47 |
»ÃСÒȤ³Ð¡ÃÃÁ¡ÒÃà¤Ã×èͧÊÓÍÒ§ ©ºÑº·Õè 13 | 1 | ![](/images/barhorange.gif) | 0.47 |
»ÃÐ⪹ì¢Í§¡ÅÙµéÒ | 1 | ![](/images/barhorange.gif) | 0.47 |
¶éÒÊѵÇìä´éÃѺ¡ÓÁжѹÁÒ¡à¡Ô¹ä» | 1 | ![](/images/barhorange.gif) | 0.47 |
¼Å¢éÒ§à¤Õ§¨Ò¡¡ÒÃãªéÂÒÅ´¤ÇÒÁÍéǹ ÀÑ¡´Õ â | 1 | ![](/images/barhorange.gif) | 0.47 |
ÂÒcentral àÁç´ÊÕªÁ¾Ù | 1 | ![](/images/barhorange.gif) | 0.47 |
¡®ËÁÒ¡ÒÃãªé¼§ªÙÃÊ | 1 | ![](/images/barhorange.gif) | 0.47 |
ÃÐàºÕº 30 ºÒ·ÃÑ¡ÉÒ·Ø¡âä | 1 | ![](/images/barhorange.gif) | 0.47 |